Tyra Biosciences, Inc. (TYRA) Financials

TYRA Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 225.9 million 21.6 million
2023-09-30 238.4 million 16.2 million
2023-06-30 250.0 million 11.4 million
2023-03-31 -101.3 million 2.3 million

TYRA Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -14.1 million 4.2 million
2023-09-30 -17.2 million 4.4 million
2023-06-30 -9.7 million 2.5 million
2023-03-31 -9.9 million 2.4 million

TYRA Net Income

No data available :(

TYRA Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 - - 6.5 million
2023-09-30 215.7 million - 6.1 million
2023-06-30 232.4 million - 6.1 million
2023-03-31 241.7 million - 2.6 million

TYRA Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 43.0 million
2023-09-30 42.9 million
2023-06-30 42.6 million
2023-03-31 42.4 million

TYRA Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 603000 20.7 million 5.0 million -
2023-09-30 83000 19.3 million 4.7 million -
2023-06-30 43000 12.2 million 3.9 million -
2023-03-31 41000 10.4 million 3.9 million -

TYRA Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 - -
2023-09-30 - 82000
2023-06-30 - 86000
2023-03-31 - 83000

TYRA

Price: $15.67

52 week price:
10.38
20.67

Earnings Per Share: -1.62 USD

P/E Ratio: -13.16

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 1674

Market Capitalization: 945.4 million

Links: